Development and validation of a population pharmacokinetic model for ritonavir used as a booster or as an antiviral agent in HIV-1-infected patients
Bregt S. Kappelhoff, Alwin D.R. Huitema, Kristel M.L. Crommentuyn, Jan W. Mulder, Pieter L. Meenhorst, Eric C.M. Van Gorp, Albert T.A. Mairuhu, Jos H. Beijnen
Research output: Contribution to journal › Article › peer-review
32Citations
(Scopus)
Fingerprint
Dive into the research topics of 'Development and validation of a population pharmacokinetic model for ritonavir used as a booster or as an antiviral agent in HIV-1-infected patients'. Together they form a unique fingerprint.